2m 2m 2m 2m 2m 2m 2m
Ligand Pharma (LGND)
NASDAQ
$286.55+$2.08 (+0.73%)
Price as of Sep 11, 2026 7:58 PM EDT- $5.7BMarket Cap
- 71.63%1-Year Change
- BiotechnologyIndustry
Ligand Pharma (LGND)
$286.55+$2.08 (+0.73%)
LGND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $284.47 | ||
Change | -$4.78 (-1.65%) | ||
Open | $291.48 | ||
High | $294.00 | ||
Low | $283.77 | ||
Previous Close | $289.25 | ||
Volume | 261,166 | ||
30-Day Average Volume | 201,570 | ||
1-Week Change | -0.40% | ||
1-Month Change | -1.48% | ||
1-Year Change | 71.63% | ||
3-Year Change | 347.07% | ||
5-Year Change | 107.90% | ||
Fundamentals | |||
Shares Outstanding | 19.9M | ||
Total Assets | $2.2B | ||
Market Cap | $5.7B | ||
Enterprise Value | $6.0B | ||
Period: QTR TTM FY | |||
Revenue | $37.4M | ||
Net Income | $48.5M | ||
Free Cash Flow | $24.0M | ||
EBIT | $65.9M | ||
EBITDA | $74.1M | ||
Net Working Capital | $1.4B | ||
EPS | $2.22 | ||
Enterprise Value/EBITDA | 81 | ||
Enterprise Value/Revenue | 161 | ||
P/B | 6 | ||
P/E | 128 | ||
PEG | 0 | ||
Price/Free Cash Flow | 236 | ||
Price/Operating Cash Flow | 236 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/02/2010 | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 11/19/2010 | ||
Earnings & Revenue